Literature DB >> 22158106

Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1.

Gu Gong1, Li-bang Yuan, Ling Hu, Wei Wu, Liang Yin, Jing-li Hou, Ying-hai Liu, Le-shun Zhou.   

Abstract

AIM: To investigate the neuroprotective effect of glycyrrhizin (Gly) against the ischemic injury of rat spinal cord and the possible role of the nuclear protein high-mobility group box 1 (HMGB1) in the process.
METHODS: Male Sprague-Dawley rats were subjected to 45 min aortic occlusion to induce transient lumbar spinal cord ischemia. The motor functions of the animals were assessed according to the modified Tarlov scale. The animals were sacrificed 72 h after reperfusion and the lumbar spinal cord segment (L2-L4) was taken out for histopathological examination and Western blotting analysis. Serum inflammatory cytokine and HMGB1 levels were analyzed using ELISA.
RESULTS: Gly (6 mg/kg) administered intravenously 30 min before inducing the transient lumbar spinal cord ischemia significantly improved the hind-limb motor function scores, and reduced the number of apoptotic neurons, which was accompanied by reduced levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) in the plasma and injured spinal cord. Moreover, the serum HMGB1 level correlated well with the serum TNF-α, IL-1β and IL-6 levels during the time period of reperfusion.
CONCLUSION: The results suggest that Gly can attenuate the transient spinal cord ischemic injury in rats via reducing inflammatory cytokines and inhibiting the release of HMGB1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158106      PMCID: PMC4010273          DOI: 10.1038/aps.2011.151

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  34 in total

1.  Reducing postischemic paraplegia using conjugated superoxide dismutase.

Authors:  J M Agee; T Flanagan; L H Blackbourne; I L Kron; C G Tribble
Journal:  Ann Thorac Surg       Date:  1991-06       Impact factor: 4.330

2.  Xanthine oxidase in experimental spinal cord injury.

Authors:  J Xu; J S Beckman; E L Hogan; C Y Hsu
Journal:  J Neurotrauma       Date:  1991       Impact factor: 5.269

3.  Evolution of operative strategies in open thoracoabdominal aneurysm repair.

Authors:  Mark F Conrad; Emel A Ergul; Virendra I Patel; Matthew R Cambria; Glenn M Lamuraglia; Mirela Simon; Richard P Cambria
Journal:  J Vasc Surg       Date:  2011-02-11       Impact factor: 4.268

4.  Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation.

Authors:  K Hirose; K Okajima; Y Taoka; M Uchiba; H Tagami; K Nakano; J Utoh; H Okabe; N Kitamura
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

5.  Stimulation of neutrophils by tumor necrosis factor.

Authors:  S J Klebanoff; M A Vadas; J M Harlan; L H Sparks; J R Gamble; J M Agosti; A M Waltersdorph
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

6.  Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C.

Authors:  T G van Rossum; A G Vulto; W C Hop; S W Schalm
Journal:  Am J Gastroenterol       Date:  2001-08       Impact factor: 10.864

7.  Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury.

Authors:  Liqun Yang; Peter C Blumbergs; Nigel R Jones; Jim Manavis; Ghafar T Sarvestani; Mounir N Ghabriel
Journal:  Spine (Phila Pa 1976)       Date:  2004-05-01       Impact factor: 3.468

8.  Neuroprotective effects of FK-506, L-carnitine and azathioprine on spinal cord ischemia-reperfusion injury.

Authors:  Serdar Akgun; Atike Tekeli; Ozlem Kurtkaya; Ali Civelek; Selim C Isbir; Koray Ak; Sinan Arsan; Aydin Sav
Journal:  Eur J Cardiothorac Surg       Date:  2004-01       Impact factor: 4.191

9.  Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair.

Authors:  Arnt E Fiane; Vibeke Videm; Per S Lingaas; Lars Heggelund; Erik W Nielsen; Odd R Geiran; Michael Fung; Tom E Mollnes
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

Review 10.  Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function.

Authors:  S Müller; L Ronfani; M E Bianchi
Journal:  J Intern Med       Date:  2004-03       Impact factor: 8.989

View more
  29 in total

1.  High mobility group box-1 (HMGB1) is increased in injured mouse spinal cord and can elicit neurotoxic inflammation.

Authors:  Kristina A Kigerl; Wenmin Lai; Lindsay M Wallace; Huan Yang; Phillip G Popovich
Journal:  Brain Behav Immun       Date:  2017-11-23       Impact factor: 7.217

2.  Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway.

Authors:  Chang-lin Zhai; Mei-qi Zhang; Yun Zhang; Hong-xia Xu; Jing-min Wang; Gui-peng An; Yuan-yuan Wang; Li Li
Journal:  Acta Pharmacol Sin       Date:  2012-10-15       Impact factor: 6.150

Review 3.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

4.  Glycyrrhizin suppresses inflammation and cell apoptosis by inhibition of HMGB1 via p38/p-JUK signaling pathway in attenuating intervertebral disc degeneration.

Authors:  Xiao Liu; Jian Zhuang; Deguo Wang; Lanxin Lv; Fenghui Zhu; Aiming Yao; Tie Xu
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

5.  Glycyrrhizin suppresses HMGB1 inductions in the hippocampus and subsequent accumulation in serum of a kainic acid-induced seizure mouse model.

Authors:  Lidan Luo; Yinchuan Jin; Il-Doo Kim; Ja-Kyeong Lee
Journal:  Cell Mol Neurobiol       Date:  2014-06-12       Impact factor: 5.046

6.  Adolescent binge ethanol treatment alters adult brain regional volumes, cortical extracellular matrix protein and behavioral flexibility.

Authors:  Leon Garland Coleman; Wen Liu; Ipek Oguz; Martin Styner; Fulton T Crews
Journal:  Pharmacol Biochem Behav       Date:  2013-11-23       Impact factor: 3.533

7.  Glycyrrhizin attenuates kainic Acid-induced neuronal cell death in the mouse hippocampus.

Authors:  Lidan Luo; Yinchuan Jin; Il-Doo Kim; Ja-Kyeong Lee
Journal:  Exp Neurobiol       Date:  2013-06-27       Impact factor: 3.261

Review 8.  Development and treatments of inflammatory cells and cytokines in spinal cord ischemia-reperfusion injury.

Authors:  Ping Zhu; Jia-xin Li; Masayuki Fujino; Jian Zhuang; Xiao-Kang Li
Journal:  Mediators Inflamm       Date:  2013-07-14       Impact factor: 4.711

9.  Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling.

Authors:  Jian Y Zou; Fulton T Crews
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

10.  The proinflammatory cytokine high-mobility group box-1 mediates retinal neuropathy induced by diabetes.

Authors:  Ahmed M Abu El-Asrar; Mohammad Mairaj Siddiquei; Mohd Imtiaz Nawaz; Karel Geboes; Ghulam Mohammad
Journal:  Mediators Inflamm       Date:  2014-03-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.